(VIANEWS) - Square (SQ), MEDIFAST (MED), Chart Industries (GTLS) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Square (SQ)
52.1% sales growth and 17.37% return on equity
Square, Inc. provides, together with its subsidiaries, payment and point-of-sale solutions in the United States and internationally.
Square's sales growth this year is anticipated to be 100.4% and 12.1% for next year.
Year-on-year quarterly revenue growth grew by 266.2%, now sitting on 13.17B for the twelve trailing months.
Volume
Today's last reported volume for Square is 4824790 which is 39% below its average volume of 7910660.
Square's sales growth is a negative 0% for the present quarter and 52.1% for the next. The company's growth estimates for the ongoing quarter and the next is 72.2% and 14.7%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 17.37%.
Volatility
Square's last day, last week, and last month's current volatility was 0.90%, 0.90%, and 2.12%, respectively.
Square's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.49% (day), 2.92% (last week), and 4.34% (last month), respectively.
Square's Stock Yearly Top and Bottom Value
Square's stock is valued at $269.74 at 06:22 EST, under its 52-week high of $289.23 and way above its 52-week low of $134.00.
Square's Moving Average
Square's worth is higher than its 50-day moving average of $260.04 and way above its 200-day moving average of $240.99.Previous days news about Square(SQ)
- According to FXStreet on Tuesday, 31 August, "Pershing Square SPAC (PSTH) is to buy an extra 2.9% of Universal Music Group (UMG)."
2. MEDIFAST (MED)
48.7% sales growth and 96.64% return on equity
Medifast, Inc., through its subsidiaries, manufactures and distributes weight loss, weight management, healthy living products, and other consumable health and nutritional products in the United States and the Asia-Pacific.
MEDIFAST's sales growth this year is expected to be 63.1% and 16.1% for next year.
Year-on-year quarterly revenue growth grew by 79.2%, now sitting on 1.27B for the twelve trailing months.
Volume
Today's last reported volume for MEDIFAST is 188711 which is 79.84% above its average volume of 104929.
MEDIFAST's sales growth for the next quarter is 48.7%. The company's growth estimates for the current quarter and the next is 69.4% and 5.8%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 96.64%.
Volatility
MEDIFAST's last day, last week, and last month's current volatility was 1.10%, 1.54%, and 2.01%, respectively.
MEDIFAST's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 3.38% (day), 3.57% (last week), and 3.81% (last month), respectively.
MEDIFAST's Stock Yearly Top and Bottom Value
MEDIFAST's stock is valued at $232.16 at 06:22 EST, way under its 52-week high of $336.99 and way above its 52-week low of $139.59.
MEDIFAST's Moving Average
MEDIFAST's worth is below its 50-day moving average of $252.27 and way below its 200-day moving average of $261.21.3. Chart Industries (GTLS)
37.5% sales growth and 6.11% return on equity
Chart Industries, Inc. manufactures and sells engineered equipment for the energy and industrial gas industries worldwide.
Chart Industries's sales growth this year is expected to be 18.5% and 20.9% for next year.
Year-on-year quarterly revenue growth grew by 11.2%, now sitting on 1.2B for the twelve trailing months.
Volume
Today's last reported volume for Chart Industries is 257837 which is 36.88% below its average volume of 408507.
Chart Industries's sales growth for the next quarter is 37.5%. The company's growth estimates for the current quarter and the next is 49.2% and 15%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 6.11%.
Volatility
Chart Industries's last day, last week, and last month's current volatility was 1.13%, 1.12%, and 1.52%, respectively.
Chart Industries's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 2.92% (day), 3.24% (last week), and 3.43% (last month), respectively.
Chart Industries's Stock Yearly Top and Bottom Value
Chart Industries's stock is valued at $192.90 at 06:22 EST, below its 52-week high of $197.40 and way above its 52-week low of $62.12.
Chart Industries's Moving Average
Chart Industries's worth is way higher than its 50-day moving average of $168.11 and way higher than its 200-day moving average of $152.12.4. Synopsys (SNPS)
11.1% sales growth and 17.2% return on equity
Synopsys, Inc. provides electronic design automation software products used to design and test integrated circuits.
Synopsys's sales growth this year is anticipated to be 14.1% and 9.7% for next year.
Year-on-year quarterly revenue growth grew by 18.9%, now sitting on 3.98B for the twelve trailing months.
Volume
Today's last reported volume for Synopsys is 679525 which is 3.71% below its average volume of 705767.
Synopsys's sales growth is a negative 0% for the present quarter and 11.1% for the next. The company's growth estimates for the current quarter and the next is 2.3% and 13.3%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 17.2%.
Volatility
Synopsys's last day, last week, and last month's current volatility was 1.23%, 0.92%, and 1.06%, respectively.
Synopsys's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.07% (day), 1.25% (last week), and 1.66% (last month), respectively.
Synopsys's Stock Yearly Top and Bottom Value
Synopsys's stock is valued at $336.64 at 06:22 EST, under its 52-week high of $340.55 and way above its 52-week low of $193.55.
Synopsys's Moving Average
Synopsys's worth is way higher than its 50-day moving average of $296.17 and way above its 200-day moving average of $263.47.Previous days news about Synopsys(SNPS)
- Synopsys insider sold over $3.34 million in company stock. According to Benzinga on Wednesday, 1 September, "Roy Vallee, Director at Synopsys (NASDAQ:SNPS), made a large insider sell on August 30, according to a new SEC filing.", "What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Monday, showed thatRoy Vallee sold 10,000 Synopsys shares, for a total of $3,339,964."
5. F5 Networks (FFIV)
7% sales growth and 13.72% return on equity
F5 Networks, Inc. provides multi-cloud application services for the security, performance, and availability of network applications, servers, and storage systems.
F5 Networks's sales growth this year is anticipated to be 10% and 7% for next year.
Year-on-year quarterly revenue growth grew by 11.7%, now sitting on 2.54B for the twelve trailing months.
Volume
Today's last reported volume for F5 Networks is 447897 which is 3.08% below its average volume of 462163.
F5 Networks's sales growth for the next quarter is 7%. The company's growth estimates for the present quarter and the next is 13.2% and 6.6%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 13.72%.
Volatility
F5 Networks's last day, last week, and last month's current volatility was 0.12%, 0.46%, and 0.68%, respectively.
F5 Networks's current volatility rank, which measures how volatile a financial asset is (variation between the lowest and highest value in a period), was 1.22% (day), 1.70% (last week), and 1.55% (last month), respectively.
F5 Networks's Stock Yearly Top and Bottom Value
F5 Networks's stock is valued at $203.61 at 06:22 EST, under its 52-week high of $216.15 and way higher than its 52-week low of $116.79.